Every living thing is colonized by microbes: the microbiome. If we consider a host’s microbiome as an organism in its own right, the relationship between the microbiome and its host is largely symbiotic, both members conferring benefits to each other through a dynamic balance. However, if the microbiome or host becomes perturbed in some manner, this can lead to dysbiosis and pathology: an imbalance. During periods of dysbiosis, which result in the development of disease, plants are able to recruit microbes as a mechanism of defense. These microbes often inhibit disease through the production of antibiotic metabolites or growth promotion, or through direct parasitism on the pathogen.
Microbiomes are highly specific to the colonized host, and can be affected considerably by situational pressures. However, many biopesticides that are currently available on the market are generic strains of microbes demonstrating general antifungal properties. Such treatments are broadly marketed as suitable for use on a variety of crops and plants, but, they are often ineffective. Generally speaking, this inadequacy in treatment efficiency can be linked to a lack of targeted specificity in active ingredients: for example, a bacterium which acts as an anti-fungal on tomato plants may not be able to do something similar in the environment presented by alfalfa. In many large-scale agricultural environments, pests can also become resistant to generic chemical and biological treatments, leading to the development of strains of pests that are incredibly difficult to treat consistently and successfully.
We isolate beneficial microbes from cannabis biomes, specifically, and return them to the plants at therapeutic levels. This means that our therapies are highly targeted, using microbes that have evolved naturally with the plant biome. We add nothing – we only enhance the natural capacity of plants to protect themselves.